Corixa Corporation

Type: Company

Name: Corixa Corporation

First reported Apr 15 2013 - Updated Apr 15 2013 - 1 reports

Rewarding High-Risk Innovation: The Case for Carried Interest

As Washington grapples with the deficit, nothing generates more emotion than tax “loopholes.” A priority “loophole” target in the budget that President Obama sent to Congress last week is the treatment of managers’ carried interest in private equity funds ... [Published Xconomy - Apr 15 2013]

Entities: Carried Interest, Capital Gain, Venture capitalist

First reported Jan 07 2013 - Updated Jan 07 2013 - 1 reports

Corixa Corporation

InterWest Partners Promotes Doug Fisher

InterWest Partners promoted Doug Fisher to partner. He joined the firm in 2009 as a principal, focusing on investments in molecular diagnostics, biotech and medical devices. Last year, Fisher led new investments in Sera Prognostics and Obalon ... [Published PE Hub News - Jan 07 2013]

Entities: Doug Fisher, InterWest Partners, Corixa Corporation, Sera Prognostics Inc

Quotes

Exemplary framework positions for substitution are described in PCT Application No. PCT/CH2008/000285, entitled "Methods of Modifying Antibodies, and Modified Antibodies with Improved Functional Properties" , filed on Jun. 25, 2008, and PCT Application No...

Stable and soluble antibodies inhibiting VEGF [Published PharmCast - Jan 23 2013]

More Content

sort by: Date \| Relevance
Rewarding High-Risk Innovation: The Case for Ca... [Published Xconomy - Apr 15 2013]
Allergy Therapeutics' MPL-based sublingual alle... [Published PharmaBiz - Mar 13 2013]
Blaze Bioscience Scores $8.5M [Published PE Hub News - Feb 22 2013]
Stable and soluble antibodies inhibiting VEGF [Published PharmCast - Jan 23 2013]
InterWest Partners Promotes Doug Fisher [Published PE Hub News - Jan 07 2013]